MedComm (Jul 2024)

Association between Hepatitis B virus infection and liver metastasis in colorectal cancer

  • Chenqin Le,
  • Chengcheng Liu,
  • Bin Lu,
  • Xinbin Zhou,
  • Yeernaer Jiamaliding,
  • Tian Jin,
  • Siqi Dai,
  • Jun Li,
  • Kefeng Ding,
  • Qian Xiao

DOI
https://doi.org/10.1002/mco2.584
Journal volume & issue
Vol. 5, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract The association between Hepatitis B virus (HBV) infection and colorectal liver metastases (CRLM) remains ambiguous in current population‐based evidence. To clarify this, we present a retrospective analysis of 5871 colorectal cancer (CRC) patients. Propensity score matching (PSM) was applied to harmonize age and sex disparities within HBV+ (n = 1696) and HBV‐ (n = 4175) groups and further within HBV+ subgroups of chronic (CHB, n = 474) and occult (OHB, n = 1222) infections. Our initial results indicated a significant association between HBV infection and synchronous colorectal liver metastasis (SYN‐CRLM); however, this association dissipated after PSM was employed to adjust for confounding variables. No significant association was observed between HBV infection and metachronous colorectal liver metastases (MET‐CRLM) both before and after PSM. Further analysis revealed that HBV replication status did not influence the incidence of CRLM. However, HBV+ participants demonstrated an increased incidence of metachronous extrahepatic metastases, particularly to the lungs. Our findings imply that neither past nor present HBV infection is significantly correlated with the occurrence of SYN‐CRLM or MET‐CRLM. The absence of an association between HBV replication status and CRLM incidence highlights the importance of incorporating a broader range of factors in the clinical management of CRLM beyond the status of HBV infection.

Keywords